Glickman Urological & Kidney Institute Outcomes
Surgical Quality Improvement
Nephrectomy Outcomes
Nephrectomy ACS NSQIP Outcomes
January 1, 2022 – December 31, 2022
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s nephrectomy ACS NSQIP performance benchmarked against 133 participating sites.
| Nephrectomy (133 Sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Morbidity | 215 | 9.77% | 8.77% |
| Cardiac | 215 | 0.00% | 0.93% |
| Pneumonia | 215 | 0.93% | 1.90% |
| Deep Vein Thrombosis (DVT) / Pulmonary Embolus | 215 | 1.86% | 1.14% |
| Renal Failure | 215 | 3.72% | 3.29% |
| Urinary Tract Infection (UTI) | 215 | 0.93% | 1.29% |
| Surgical Site Infection (SSI) | 215 | 2.33% | 2.83% |
| Sepsis | 215 | 1.40% | 0.87% |
| Length of Stay | 192 | 25.00% | 20.33% |
| Unplanned Readmission | 215 | 10.23% | 6.71% |
| Rectal Injury | 215 | 0.00% | 0.16% |
| Prolonged NPO/NGT Use | 215 | 1.86% | 2.15% |
| Lymphocele/Leak/Fluid | 215 | 0.93% | 1.81% |
American College of Surgeons National Surgical Quality Improvement Program, 2023.
ACS NSQIP® Semiannual Report July 3, 2023, Chicago: American College of Surgeons.
